ArticlePloS one2015

Oral Administration of 4-Hydroxy-3-Methoxycinnamaldehyde Attenuates Atopic Dermatitis by Inhibiting T Cell and Keratinocyte Activation.

Hyun-Su Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.